Predict your next investment

HEALTHCARE | Biotechnology

See what CB Insights has to offer


Series B | Dead

About Congenics

Provider of genetic technology. The company focuses on medical genetics, candidate gene studies, and genome-wide association analysis for the elucidation of the genetic causes of pharmacological side effects and rare diseases such as obesity, diabetes, and cancer. [Keywords: tumor]

Congenics Headquarter Location

Grandweg 64

Hamburg, 22529,


49 40 429 346 40

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Congenics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Congenics is included in 1 Expert Collection, including Diabetes.



1,734 items

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.